This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 737817
Features Image
The Axone project

The Axone lead

This project aims to develop and commercialize an ultra-thin left ventricular lead that is 5 times smaller in diameter than state-of-the-art cardiac leads today. The Axone lead will provide a solution for heart failure patients with cardiac desynchronization who were untreated due to difficult coronary venous access, and improve the outcome of patients who are currently not responding or poorly responding to treatment.

Clinical Study

Pre-market and post-market


Acute study

• Design validation
• Acute single and multi-zone pacing


ASTRAL-4LV Chronic study

• Chronic safety and performance


Benefit and claims

• Sponsored or investigator initiated


Post market follow-up

• Registry or real-world evidence

Contact Us

    the terms of use
    The data collected through this contact form will be processed by the Axone project. They allow the Axone project to manage its contacts and will be stored in its contacts database for a duration of three years as of the last interaction with the Axone project. The contact form has mandatory data fields which allow us to answer your request. Non-mandatory data fields have no incidence on processing your request. You have the right to access your data and can ask for their erasure. You also have the rights to opposition of processing, rectification, data portability and restriction of data processing (you can consult or To exercise these rights or for any question you can send a mail to If you consider that, despite this, your rights are not being respected, you can at any time file a complaint with the control authority: For further information, please check our privacy policy: